CISPLATIN — all Canadian products
12 DINs
7 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is CISPLATIN, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02409186 | CISPLATIN INJECTION | FRESENIUS KABI CANADA LTD | Solution | Intravenous | CISPLATIN 1 MG | Approved | |
| 02403188 | CISPLATIN INJECTION | TEVA CANADA LIMITED | Solution | Intravenous | CISPLATIN 1.0 MG | Marketed | |
| 02422034 | CISPLATIN INJECTION | OMEGA LABORATORIES LIMITED | Solution | Intravenous | CISPLATIN 1 MG | Approved | |
| 02393832 | CISPLATIN INJECTION | STRIDES PHARMA CANADA INC | Solution | Intravenous | CISPLATIN 1 MG | Approved | |
| 02536285 | CISPLATIN INJECTION BP | HIKMA CANADA LIMITED | Solution | Intravenous | CISPLATIN 1 MG | Marketed | |
| 02126613 | CISPLATIN INJECTION BP | PFIZER CANADA ULC | Solution | Intravenous | CISPLATIN 1 MG | Marketed | |
| 02355183 | CISPLATIN INJECTION, BP | ACCORD HEALTHCARE INC | Solution | Intravenous | CISPLATIN 1 MG | Marketed | |
| 00692743 | CISPLATIN INJ 1MG/ML | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | Intravenous | CISPLATIN 1 MG | Cancelled Post Market | |
| 02366711 | CISPLATIN INJECTION BP | SANDOZ CANADA INCORPORATED | Solution | Intravenous | CISPLATIN 1 MG | Cancelled Post Market | |
| 02396890 | CISPLATIN INJECTION, MYLAN STD. | MYLAN PHARMACEUTICALS ULC | Solution | Intravenous | CISPLATIN 1 MG | Cancelled Post Market | |
| 00788740 | PLATINOL AQ INJ 1MG/ML | BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | Liquid | Intravenous | CISPLATIN 1 MG | Cancelled Post Market | |
| 02409194 | PMS-CISPLATIN | PHARMASCIENCE INC | Solution | Intravenous | CISPLATIN 1 MG | Cancelled Pre Market |
Browse other molecules: